Skip to main content
  • sickle-cell-clot

    Pawlinski, Key Awarded $2.8 Million Grant To Study VTE in Sickle Cell Disease

    Rafal Pawlinski, PhD, the Lenvil Lee Rothrock Distinguished Professor of Medicine, and Nigel Key, MD, the Harold R. Roberts Distinguished Professor, both professors in the department of medicine’s division of hematology and members of the UNC Blood Research Center, have been awarded a $2.8 million, 4-year R01 grant from the NIH-NHLBI to investigate the mechanism of venous thrombo … Read more

  • Raj Kasthuri, MD

    Kasthuri Leads Post-Hospital Thrombosis Prevention Study For Covid Patients

    UNC is now a fully active clinical site for the ACTIV-4c Post-Hospital Thrombosis Prevention Study. This protocol is part of the larger ACTIV (Accelerating COVID-Therapeutic Interventions and Vaccine) study. This protocol focuses on preventing blood clots in patients discharged after being hospitalized with COVID-19. UNC is now enrolling participants in this adaptive, prospective … Read more

  • Nigel S. Key, MB, ChB, FRCP

    Can AstraZeneca Dispel Doubts About Its Shots?

    The AstraZeneca shot was supposed to be the vaccine for a couple of billion people. But after reports the shot may trigger a rare side effect, public health officials worry that the people in some countries may have lost faith in the world’s most important vaccine. In an article published by and National Geographic, Nigel Key, MD, the Harold R. Roberts Distinguished Profe … Read more

  • March- Grants and Funding

    Department of Medicine Grants & Funding: March 1 – March 31, 2021

    Division of Hematology Patrick Ellsworth, MD, received a Research Restart Award from the American Society of Hematology, which helps ensure research continuity during the COVID-19 pandemic. Nigel Mackman, PhD, received a grant award for “Tissue factor-dependent coagulation in thrombosis and immune responses” from the NIH National Heart, Lung, and Blood Institute. Division of Infe … Read more

  • Nigel Key, MD

    Rare Clotting Disorder May Cloud the World’s Hopes For AstraZeneca’s COVID-19 Vaccine

    An article published in Science recognizes new concerns about the safety of the AstraZeneca’s COVID-19 vaccine, as an explanation gains ground for the unusual strokes and clotting disorders recorded in at least 30 recipients. Nigel Key, MD, the Harold R. Roberts Distinguished Professor in the division of hematology commented on the need to alert doctors as multiple researchers be … Read more

  • wohl-moll-featured-photo

    Should You Be Concerned About Blood Clots, Bleeding and the AZ-Vaccine?

    While millions of people in dozens of countries have received the AstraZeneca Covid vaccine with few reports of ill effects, and its prior testing in tens of thousands of people found it to be safe, the vaccine is being investigated. A New York Times article explains the decision to pause the vaccine in European countries, with concerns about blood clots and abnormal bleeding in … Read more

  • Ellsworth Receives ASH Research Restart Award

    Patrick Ellsworth, MD, assistant professor in the division of hematology in the UNC Department of Medicine, received a new ASH Research Restart Award to help ensure research continuity and workforce stability during the COVID-19 pandemic.  The American Society of Hematology (ASH) announced that 19 talented early-career investigators will receive critical funding to support their … Read more

  • February- Grants and Funding

    Department of Medicine Grants & Funding: February 1 – February 28, 2021

    Division of Cardiology Matthew Cavender, MD, received a grant from the NHLBI via the UNC Renaissance Computing Institute (RENCI) for “Team Proposal: Utilization of Machine Learning Techniques to Identify Clinical and Genetic Determinants of Calcific Aortic Valve Disease.” Division of Gastroenterology & Hepatology Andrew Moon, MD, MPH, and Louise Henderson, PhD, professor of r … Read more

  • January- Grants and Funding

    Department of Medicine Grants & Funding: January 1 – January 31, 2021

    Division of General Medicine Seth Berkowitz, MD, received a new, five-year R01 grant to broaden clinical studies of medically-tailored meal delivery. Division of Hematology Erica Sparkenbaugh, MD, was awarded a five-year, $2 million R01 grant from NIH-NHLBI to evaluate whether activation of beneficial PAR1 signaling can attenuate the chronic pro-coagulant state of sickle cell dis … Read more

  • stephan-moll

    COVID-19 Vaccination While on a Blood Thinner

    Clot Connect, a clearinghouse for Information about blood clots (DVT/PE) and clotting disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center, published a blog by Stephan Moll, MD, featuring guidance on COVID-19 vaccination for people on blood thinners. Read more from the UNC Health and UNC School of Medicine Newsroom.

  • December- Grants and Funding

    Department of Medicine Grants & Funding: December 1 – December 31, 2020

    Division of Hematology Nigel Mackman, PhD, FAHA, received an R35 grant from the National Heart Lung and Blood Institute of the NIH to fund the study “Tissue factor-dependent coagulation in thrombosis and immune responses.” Division of Infectious Diseases Jessica Lin, MD, MSCR, received an NIH National Institute of Allergy and Infectious Diseases R21 grant for “Plasmodium ovale hy … Read more

  • Fellows Match to the Department of Medicine

    While the pandemic made this year particularly challenging for fellowship recruitment efforts and interviews, a series of videos showing each program’s strengths was a creative solution, introducing viewers to faculty and current fellows, with a brief glimpse into what it might be like to join the program. And although it was impossible to replicate the experience of visiting in- … Read more